Monday, November 9, 2020

Axios PM: 🚨 Trump teases 2024 — Hope for COVID winter — Zoomsgiving

1 big thing: Vaccine gives hope during COVID winter | Monday, November 09, 2020
 
Axios Open in app View in browser
 
Presented By UnitedHealth Group
 
Axios PM
By Mike Allen ·Nov 09, 2020

Good afternoon: Today's PM — edited by Justin Green — is 580 words, a 2-minute read.

🚨Situational awareness:

  1. Scoop: President Trump has already told advisers he's thinking about running for president again in 2024, Jonathan Swan reported this afternoon.
  2. Defense Secretary Mark Esper "has been terminated," Trump tweeted today.
  3. More COVID in Trumpworld: HUD Secretary Ben Carson and outside adviser David Bossie have tested positive.

🎬 Join us at 11 p.m. ET/PT tonight for our "Axios on HBO" post-election blockbuster: Valerie Biden Owens ... House Republican Leader Kevin McCarthy ... House Majority Whip James Clyburn ... Georgia Senate candidate Jon Ossoff ... and Rep. Ro Khanna.

 
 
1 big thing: Vaccine gives hope during COVID winter
Data: Our World in Data; Chart: Naema Ahmed/Axios

Hope in a pandemic: Pfizer said its vaccine trial prevented symptomatic COVID-19 infections in 90% of previously uninfected people, without any serious safety concerns.

  • "The results are really quite good, I mean extraordinary," said Dr. Anthony Fauci.
  • "I'm encouraged," said Paul Offit, a physician and vaccine expert at Children's Hospital of Philadelphia.
  • Stock markets surged on the news, with the Dow up nearly 3%.

Pfizer expects to release safety data next week, CEO Albert Bourla told Axios' Dan Primack on the Re:Cap podcast.

  • Bourla says he would've released vaccine data before the election if possible.
  • The company plans to let public health officials determine who receives initial doses.
  • Pfizer did not accept government money for research and development, in order to better "liberate our scientists" and to "keep Pfizer out of politics."
  • Full transcript.

The big picture: The pandemic is surging in North America and Europe, with the U.S. recording more than 100,000 new cases a day since last week.

The good news: A successful Pfizer candidate bodes well for some of the other vaccines that are currently in trials, writes STAT's Helen Branswell.

  1. Its 90+% reported efficacy rate is far higher than the 50% bar set by the FDA, which could ease the task of getting people to sign up for a first-generation vaccine.
  2. It uses the same tech and targets the same protein as other vaccines, suggesting that those approaches could work too.

Potential obstacles, flagged by Bloomberg's Drew Armstrong.

  1. "The vaccine may work better in some groups than in others."
  2. "There could be safety concerns that limit its use — including rare side effects that take two or three months to emerge."
  3. "And the shot must be stored at ultra-low temperatures, a logistical challenge that will make distribution harder and slower."

The bottom line: "I was nervous," Bourla told Axios on the prospect of the vaccine failing to work as intended.

  • "[I]f we're not successful, we are going to lose the billion dollars. But if we're unsuccessful, the world is losing hope."
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
2. Pic du jour
Photo: Sebastien Bozon/AFP/Getty Images

A message probably lost by a carrier pigeon in 1910, sent by a German officer and miraculously found by chance in 2020 in eastern France.

Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from UnitedHealth Group

Leading in the development of a next-generation health care system
 
 

For more than 20 years, UnitedHealth Group has advocated for universal coverage.

Learn more about three solutions to build on the existing health care system to cover 28 million more people.

We're committed to expanding access to high-quality, affordable health care.

 
 
3. Catch up quick
  1. Senate Majority Leader Mitch McConnell defended Trump's refusal to concede to Joe Biden." Go deeper.
  2. GM is pulling ahead the launch of two future electric vehicles and plans to add 3,000 new software jobs by early next year. Go deeper.
  3. The right-leaning social network Parler is now topping the free app download charts. Go deeper.
  4. The billionaire son of one former Lebanese prime minister and brother of another tells Axios his younger brother must not cut any political deals with Hezbollah in order to form a new government. Go deeper.
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 
4. 🦃 The year of Zoomsgiving
Photo: Getty Images/Stock

For once, electronic devices will be socially acceptable at the Thanksgiving dinner table, since so many families will be feasting virtually. A few COVID-era hacks, via USA Today:

  • Put more guests on one side of the table than usual, so more of them are in camera range.
  • Keep it interesting for virtual guests by moving your device around during the meal.
  • Coordinate recipes, so distant tables have the same Parmesan roasted Brussels sprouts or scalloped sweet potatoes.
Share on Facebook Tweet this Story Post to LinkedIn Email this Story
 
 

A message from UnitedHealth Group

How to cover 28 million more people…
 
 
Learn how to achieve universal coverage by strengthening and expanding existing coverage options:
  • Expand and strengthen Medicaid to cover 9 million more people.
  • Modernize exchanges to cover 9 million more people.
  • Enable more choice in the individual market to cover 10 million more people.
 
 

Axios thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201
 
You received this email because you signed up for newsletters from Axios.
Change your preferences or unsubscribe here.
 
Was this email forwarded to you?
Sign up now to get Axios in your inbox.
 

Follow Axios on social media:

Axios on Facebook Axios on Twitter Axios on Instagram
 
 
                                             

No comments:

Post a Comment

J.P. Morgan preparing for market meltdown?

Why is J.P. Morgan stockpiling silver? ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...